{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:45:23Z","timestamp":1782899123859,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejim.2026.106863","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:22:54Z","timestamp":1775780574000},"page":"106863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Erectile dysfunction and antihypertensive therapy: A critical reappraisal"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4273-4489","authenticated-orcid":false,"given":"Athanasios J","family":"Manolis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8256-4218","authenticated-orcid":false,"given":"Manolis S","family":"Kallistratos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Koutsaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejim.2026.106863_bib0001","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.juro.2018.05.004","article-title":"Erectile dysfunction: AUA Guideline","volume":"200","author":"Burnett","year":"2018","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ejim.2026.106863_bib0002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41443-018-0020-z","article-title":"Relation between hypertension and erectile dysfunction: a meta-analysisof cross-section studies","volume":"30","author":"Wang","year":"2018","journal-title":"Int J Impot Res"},{"issue":"1","key":"10.1016\/j.ejim.2026.106863_bib0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-024-04020-x","article-title":"Anti-hypertensive medications and erectile dysfunction: focus on \u03b2-blockers","volume":"87","author":"Corona","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.ejim.2026.106863_bib0004","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.HYP.29.1.8","article-title":"Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: treatment of mild hypertension study (TOMHS)","volume":"29","author":"Grimm","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2026.106863_bib0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2164\/jandrol.04191","article-title":"Factors affecting the increased prevalence of erectile dysfunction in hypertensive compared to normotensive individuals","volume":"27","author":"Doumas","year":"2005","journal-title":"J Androl"},{"key":"10.1016\/j.ejim.2026.106863_bib0006","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/CIRCULATIONAHA.109.864199","volume":"121","author":"Bohm","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2026.106863_bib0007","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/HJH.0000000000000911","article-title":"SPRINT Study Group. Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT)","volume":"34","author":"Thomas","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2026.106863_bib0008","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-4295(02)02102-7","article-title":"Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction","volume":"61","author":"Nicolosi","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ejim.2026.106863_bib0009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.eururo.2003.08.005","article-title":"Determinants of erectile dysfunction risk in a large series of Italian men attending andrology clinics","volume":"45","author":"Mirone","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejim.2026.106863_bib0010","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.eururo.2003.11.020","article-title":"Effects of age, comorbidity and lifestyle factors on erectile function: tampere Ageing male urological Study (TAMUS)","volume":"45","author":"Shiri","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejim.2026.106863_bib0011","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.eururo.2004.08.017","article-title":"Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire","volume":"47","author":"Ponholzer","year":"2005","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ejim.2026.106863_bib0012","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/01.HYP.28.5.859","article-title":"Erectile dysfunction in hypertensive subjects. Assessment of potential determinants","volume":"28","author":"Jaffe","year":"1996","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.ejim.2026.106863_bib0013","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1097\/HJH.0b013e32830dd0c6","article-title":"Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications","volume":"26","author":"Manolis","year":"2008","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.ejim.2026.106863_bib0014","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1570161118666200414102556","article-title":"Erectile dysfunction as a cardiovascular risk factor: time to step up?","volume":"19","author":"Imprialos","year":"2021","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"10.1016\/j.ejim.2026.106863_bib0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/ajh\/hpaa143","article-title":"Hypertension and erectile dysfunction: breaking down the challenges","volume":"34","author":"de Oliveira","year":"2021","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ejim.2026.106863_bib0016","series-title":"Autonomic regulation of sexual function","article-title":"Neuroscience","author":"Purves","year":"2001"},{"issue":"1","key":"10.1016\/j.ejim.2026.106863_bib0017","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/15701611113119990140","article-title":"Sympathetic overactivity in hypertension and cardiovascular disease","volume":"12","author":"Manolis","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"10.1016\/j.ejim.2026.106863_bib0018","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1756287216685027","article-title":"Nebivolol versus other beta blockers in patients with hypertension and erectile dysfunction","volume":"9","author":"Sharp","year":"2017","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.ejim.2026.106863_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.009","article-title":"Erectile dysfunction and adherence to antihypertensive therapy: focus on \u03b2-blockers","volume":"81","author":"Manolis","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2026.106863_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.ijir.3900393","article-title":"Sexual dysfunction related to antihypertensive agents: results from the animal model","volume":"11","author":"Srilatha","year":"1999","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.ejim.2026.106863_bib0021","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/aja.2011.99","article-title":"Increased expression of insulin-like growth factor-binding protein-3 is implicated in erectile dysfunction in two-kidney one-clip hypertensive rats after propranolol treatment","volume":"13","author":"Zhou","year":"2011","journal-title":"Asian J Androl"},{"key":"10.1016\/j.ejim.2026.106863_bib0022","first-page":"39","article-title":"Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of medical research council working party on mild to moderate hypertension","volume":"5","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2026.106863_bib0023","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-114-8-613","article-title":"Effect of antihypertensives on sexual function and quality of life: the TAIM study","volume":"114","author":"Wassertheil-Smoller","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2026.106863_bib0024","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJM199304013281303","article-title":"Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo: the department of veterans affairs cooperative study group on antihypertensive agents","volume":"328","author":"Materson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106863_bib0025","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM198606263142602","article-title":"The effects of antihypertensive therapy on the quality of life","volume":"314","author":"Croog","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106863_bib0026","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ehj.2003.08.016","article-title":"Report of erectile dysfunction after therapy with beta blockers is related to patient knowledge of side effects and is reversed by placebo","volume":"24","author":"Silvestri","year":"2003","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ejim.2026.106863_bib0027","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10557-021-07197-9","article-title":"Effects of major antihypertensive drug classes on erectile function: a network meta-analysis","volume":"36","author":"Farmakis","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"10.1016\/j.ejim.2026.106863_bib0028","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00044011-200525060-00006","article-title":"A randomised comparison of the effects of Nebivolol and Atenolol with and without chlorthalidone on the sexual function of hypertensive men","volume":"25","author":"Boydak","year":"2005","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ejim.2026.106863_bib0029","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1440-1681.2007.04551.x","article-title":"Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men","volume":"34","author":"Brixius","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ejim.2026.106863_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5761\/atcs.oa.16-00242","article-title":"The comparison of the effects of nebivolol and metoprolol on erectile dysfunction in the cases with coronary artery bypass surgery","volume":"23","author":"Gur","year":"2017","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.ejim.2026.106863_bib0031","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/00926239208412857","article-title":"Bisoprolol and hypertension: effects on sexual functioning in men","volume":"18","author":"Broekman","year":"1992","journal-title":"J Sex Marital Ther"},{"issue":"1","key":"10.1016\/j.ejim.2026.106863_bib0032","first-page":"22","article-title":"Self reported sexual dysfunction in men and women treated with bisoprolol, hydrochlorothiazide, enalapril, amlodipine, placebo, or bisoprolol\/hydrochlorothiazide","volume":"1","author":"Prisant","year":"1999","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"5","key":"10.1016\/j.ejim.2026.106863_bib0033","article-title":"Comparison of effect of Nebivolol and Bisoprolol on sexual function of hypertensive female patients","volume":"13","author":"Kumar","year":"2021","journal-title":"Cureus"},{"issue":"Suppl 2","key":"10.1016\/j.ejim.2026.106863_bib0034","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/01.hjh.0000833056.16043.8a","article-title":"Beta-blocker treatment options and risk of erectile dysfunction: a systematic review and meta-analysis","volume":"40","author":"Sulastri","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2026.106863_bib0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ahj.2025.08.005","article-title":"Beta-blocker side-effects in clinical practice: a nationwide approach","volume":"291","author":"Rasmussen","year":"2026","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2026.106863_bib0036","first-page":"539","article-title":"Report of1981. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension","volume":"2","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2026.106863_bib0037","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/00004872-200308000-00022","article-title":"Metabolic outcome during 1 year in newly detected hypertensives: results of the antihypertensive treatment and lipid profile in a north of Sweden efficacy evaluation (ALPINE study)","volume":"21","author":"Lindholm","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2026.106863_bib0038","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-1241.2010.02563.x","article-title":"Cardiovascular risk, drugs and erectile function-a systematic analysis","volume":"65","author":"Baumh\u00e4kel","year":"2011","journal-title":"Int J Clin Pr"},{"key":"10.1016\/j.ejim.2026.106863_bib0039","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1592\/phco.21.7.676.34571","article-title":"Drug therapy and prevalence of erectile dysfunction in the Massachusetts male aging study cohort","volume":"21","author":"Derby","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejim.2026.106863_bib0040","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0022-5347(17)43582-8","article-title":"Effects of some calcium channel blockers on isolated human penile erectile tissues","volume":"138","author":"Fovaeus","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.ejim.2026.106863_bib0041","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1291\/hypres.29.523","article-title":"Treatment with hypotensive agents affects the impaired relaxation of the penile corpus cavernosum in hypertensive rats","volume":"29","author":"Ushiyama","year":"2006","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ejim.2026.106863_bib0042","doi-asserted-by":"crossref","DOI":"10.1177\/1557988319892735","article-title":"Angiotensin receptor blockers for erectile dysfunction in hypertensive men: a brief meta-analysis of randomized control trials","volume":"13","author":"Ismail","year":"2019","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.ejim.2026.106863_bib0043","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1743-6109.2005.20230.x","article-title":"Long-term effect of inhibition of the angiotensin-converting enzyme (ACE) on cavernosal perfusion in men with atherosclerotic erectile dysfunction: a pilot study","volume":"2","author":"Speel","year":"2005","journal-title":"J Sex Med"},{"issue":"1","key":"10.1016\/j.ejim.2026.106863_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.HYP.12.1.1","article-title":"Sexual dysfunction in hypertensive men. A critical review of the literature","volume":"12","author":"Bansal","year":"1988","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ejim.2026.106863_bib0045","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/00003495-200565060-00005","article-title":"Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs","volume":"65","author":"D\u00fcsing","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.ejim.2026.106863_bib0046","unstructured":"Stohs S.J. Drugs and sexual function. US Pharmacist 1978;3:52\u201366."},{"key":"10.1016\/j.ejim.2026.106863_bib0047","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0090-4295(96)00302-0","article-title":"Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results","volume":"48","author":"Lukacs","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.ejim.2026.106863_bib0048","first-page":"478","article-title":"Alfuzosin 10mg once daily improves sexual function in men with LUTS and concomitant sexual dysfunction [abstract]","volume":"169","author":"Van Moorselaar","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ejim.2026.106863_bib0049","first-page":"S3","article-title":"Sexual function and alpha-blockers","volume":"7 Suppl 8","author":"McVary","year":"2005","journal-title":"Rev Urol"},{"issue":"7","key":"10.1016\/j.ejim.2026.106863_bib0050","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/HJH.0000000000002382","article-title":"European society of hypertension working group on sexual dysfunction. Update of the position paper on arterial hypertension and erectile dysfunction","volume":"38","author":"Viigimaa","year":"2020","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.ejim.2026.106863_bib0051","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0895-7061(00)01177-8","article-title":"Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group","volume":"14","author":"Kloner","year":"2001","journal-title":"Am J Hypertens"},{"issue":"41","key":"10.1016\/j.ejim.2026.106863_bib0052","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1055\/s-2001-17743","article-title":"Wechselwirkungen zwischen Sildenafil und Antihypertensiva - was ist gesichert? [Interaction between sildenafil and antihypertensive drugs: what is evidence-based?]","volume":"126","author":"Rosenkranz","year":"2001","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"10.1016\/j.ejim.2026.106863_bib0053","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCULATIONAHA.110.944603","article-title":"Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejim.2026.106863_bib0054","first-page":"265","article-title":"Update on drug interactions with phosphodiesterase-5 inhibitors prescribed as first-line therapy for patients with erectile dysfunction or pulmonary hypertension","volume":"14","author":"Gur","year":"2013","journal-title":"Curr Drug Metab"},{"issue":"2","key":"10.1016\/j.ejim.2026.106863_bib0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/jsxmed\/qdad163","article-title":"Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health","volume":"21","author":"Kloner","year":"2024","journal-title":"J Sex Med"},{"issue":"8","key":"10.1016\/j.ejim.2026.106863_bib0056","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIR.0b013e3182447787","volume":"125","author":"Levine","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejim.2026.106863_bib0057","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41569-021-00593-6","article-title":"Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs","volume":"19","author":"Terentes-Printzios","year":"2022","journal-title":"Nat Rev Cardiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526001688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526001688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:45:23Z","timestamp":1782895523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526001688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":57,"alternative-id":["S0953620526001688"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106863","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erectile dysfunction and antihypertensive therapy: A critical reappraisal","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106863","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106863"}}